Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M720Revenue $M247Net Margin (%)6.1Z-Score3.0
Enterprise Value $M713EPS $0.4Operating Margin %10.0F-Score5
P/E(ttm))46.1Cash Flow Per Share $0.7Pre-tax Margin (%)7.3Higher ROA y-yY
Price/Book2.910-y EBITDA Growth Rate %0Quick Ratio4.3Cash flow > EarningsN
Price/Sales2.75-y EBITDA Growth Rate %0Current Ratio5.2Lower Leverage y-yN
Price/Cash Flow7.4y-y EBITDA Growth Rate %50.0ROA % (ttm)3.9Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)6.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M32.4ROI % (ttm)1.7Gross Margin Increase y-yY

Gurus Latest Trades with AMRI

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMRIJoel Greenblatt 2014-06-30 Reduce-0.03%$14.63 - $19.89
($16.89)
$ 22.3532%Reduce -47.95%102,934
AMRIGeorge Soros 2014-06-30 Sold Out -0.01%$14.63 - $19.89
($16.89)
$ 22.3532%Sold Out0
AMRIGeorge Soros 2014-03-31 Buy 0.01%$10.08 - $19.91
($13.57)
$ 22.3565%New holding, 48700 sh.48,700
AMRIJoel Greenblatt 2013-09-30 Buy 0.1%$10.81 - $13.72
($12.29)
$ 22.3582%New holding, 228216 sh.228,216
AMRIJean-Marie Eveillard 2010-12-31 Sold Out $5.05 - $6.93
($5.92)
$ 22.35278%Sold Out0
AMRIJean-Marie Eveillard 2010-06-30 Buy $5.1 - $8.86
($7.07)
$ 22.35216%New holding, 10000 sh.10,000
AMRIGeorge Soros 2007-12-31 Sold Out -0.01%$11.98 - $18.2
($14.8)
$ 22.3551%Sold Out0
AMRIGeorge Soros 2007-09-30 Buy 0.01%$13.59 - $16.48
($15)
$ 22.3549%New holding, 14780 sh.14,780
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AMRI is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
AMRI Joel Greenblatt 2014-06-30102,9340.320.03-47.95%
AMRI George Soros 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


AMRI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
D AMBRA CONSTANCE M10% Owner 2014-09-10Sell20,000$20.1213.77view
D AMBRA THOMAS E PHDDirector 2014-09-10Sell20,000$20.1213.77view
CABLE STUART M10% Owner 2014-09-02Sell30,000$19.318.6view
HENDERSON LORI MSVP, Secretary & Gen. Counsel 2014-09-02Sell2,500$19.5617.02view
Hagen Steven RSVP Pharmaceutical Dev & Mfg 2014-08-28Sell1,250$19.7415.96view
Nolan Michael MSVP, CFO and Treasurer 2014-08-14Sell10,000$19.7615.84view
HENDERSON LORI MSVP, Secretary & Gen. Counsel 2014-08-12Sell30,000$19.0520.16view
D AMBRA CONSTANCE M10% Owner 2014-08-11Sell20,000$18.9920.54view
D AMBRA THOMAS E PHDDirector 2014-08-11Sell20,000$18.9920.54view
Hagen Steven RSVP Pharmaceutical Dev & Mfg 2014-08-08Sell10,797$18.9920.54view

Press Releases about AMRI :

    Quarterly/Annual Reports about AMRI:

    News about AMRI:

    Articles On GuruFocus.com
    Weekly CFO Buys Highlight: TSON, PRTS, FXCM, AMRI, MN Dec 05 2011 
    View on AMRI Jun 27 2010 
    AMRI Announces Second Quarter 2009 Results Aug 04 2009 
    AMRI Announces Fourth Quarter 2008 Results Feb 09 2009 
    AMRI Names Senior Director, Analytical and Quality Services Jan 12 2009 

    More From Other Websites
    Insider Trading Alert - BRCM, CI And AMRI Traded By Insiders Sep 15 2014
    ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K/A, Completion of Acquisition or Disposition of... Sep 12 2014
    Albany Molecular Resh (AMRI) Upgraded From Hold to Buy Sep 11 2014
    New Platforms Enhance AMRI's Discovery Biology Offerings Sep 04 2014
    AMRI CEO to Present at the Morgan Stanley Global Healthcare Conference Aug 26 2014
    ALBANY MOLECULAR RESEARCH INC Financials Aug 19 2014
    ALBANY MOLECULAR RESEARCH INC Files SEC form 10-Q, Quarterly Report Aug 11 2014
    Albany Molecular Research Inc. Co-Founder Thomas D'Ambra Joins ACPHS Board of Trustees Aug 06 2014
    Albany Molecular Research Inc Stock Downgraded (AMRI) Aug 06 2014
    ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 05 2014
    AMRI Announces Second Quarter 2014 Results Aug 05 2014
    Q2 2014 Albany Molecular Research Inc Earnings Release - Before Market Open Aug 05 2014
    AMRI to Announce Second Quarter Results Jul 22 2014
    ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Completion of Acquisition or Disposition of... Jul 07 2014
    Albany Molecular's Oso Buy Seen Boosting Earnings Jul 07 2014
    Insider Trading Alert - VNTV, SNCR And AMRI Traded By Insiders Jul 03 2014
    AMRI Completes Acquisition of Oso Biopharmaceuticals Manufacturing Jul 01 2014
    AMRI Completes Acquisition of Oso Biopharmaceuticals Manufacturing Jul 01 2014
    AMRI Announces Early Termination of HSR Waiting Period for Acquisition of Oso Biopharmaceuticals... Jun 23 2014
    ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K/A, Completion of Acquisition or Disposition of... Jun 20 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK